Bolt Biotherapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Bolt Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Bolt Biotherapeutics Inc
Rating: 1.46958325
Author: Trendlyne DVM scores

about

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloi...

6.19 -0.13 (-2.06%)

60.32% Fall from 52W High

15,024

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

27.3 / 100

Technically Bearish

31.5 / 100

1Yr Price target upside is 546%

3 analysts

Bolt Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bolt Biotherapeutics Inc Live Share Price Today, Share Analysis and Chart

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloi...

60.32% Fall from 52W High

SWOT Analysis

Bolt Biotherapeutics Inc Live Price Chart